Synergistic Inhibition of Pro-Inflammatory Pathways by Ginger and Turmeric Extracts in RAW 264.7 Cells

Area of Science:

• Pharmacology and Herbal Medicine
• Immunology and Inflammation Research
• Molecular Biology and Signaling Pathways

Background:

• Herbal medicines often exhibit synergy, enhancing potency and therapeutic windows through complex mechanisms.
• Understanding the multi-targeted synergistic effects of herbal combinations is crucial for therapeutic development.
• Lipopolysaccharides (LPS) induce inflammatory pathways, making them a relevant model for studying anti-inflammatory agents.

Purpose of the Study:

• To investigate the synergistic anti-inflammatory mechanism of a ginger (G) and turmeric (T) extract combination (GT).
• To explore GT's modulatory activity on LPS-induced inflammatory pathways and key molecular targets.
• To assess GT's efficacy in downregulating pro-inflammatory mediators and signaling at miRNA and protein levels.

Main Methods:

• Utilized Bioplex ProTM cytokine assay to assess anti-cytokine activity in LPS-activated RAW 264.7 cells.
• Measured nitric oxide (NO), tumor necrosis factor (TNF), and interleukin (IL)-6 inhibition using Griess reagents and ELISA.
• Employed immunofluorescence, Western blot, and real-time PCR to investigate effects on LPS/TLR4 signaling and miR-155-5p.

Main Results:

• GT synergistically attenuated inducible NO, TNF, IL-6, GM-CSF, and MCP-1 production.
• GT significantly inhibited LPS-induced NF-kB p65 translocation, TLR4 activation, TRAF6, and JNK/c-JUN phosphorylation.
• GT demonstrated superior suppression of miR-155-5p compared to individual G or T extracts.

Conclusions:

• GT exhibits synergistic anti-inflammatory activity through multi-targeted mechanisms at both miRNA and protein levels.
• The combination of ginger and turmeric offers a potent therapeutic candidate for inflammatory diseases.
• This study provides a scientific basis for the combined use of ginger and turmeric in managing inflammation.